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cases of dermatofibroma; 8 cases of dermal scars; 5 cases of deep-seated
fibrous histiocytoma. The antibody against the N- terminal portion of WT1-
6F-H2, was used.
Results: Themajority of dermatofibrosarcomas protuberans (54 out of 57),
exhibited cytoplasmic staining for WT1. The immunohistochemical ex-
pression was diffuse, heterogeneous or focal, respectively, in 75%, 15%
and 6%of cases.With the exception of 4 cases showing aweak tomoderate
staining in different areas of the same tumour, the staining intensity was
diffuse and strong. All recurrent tumours showed diffuse and strong WT1
cytoplasmic immunoreactivity while the fibroblasts of the associated scar
tissue were negative. None of the other tumour or tumour-like, bland-
looking spindle cell lesions examined, were WT1-positive.
Conclusion: WT1 is an ancillary immunomarker, exploitable in combi-
nation with CD34, in confirming the diagnosis of dermatofibrosarcoma
protuberans, including in the recurrent tumours.
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Background & objectives: BRAF mutation in melanoma predicts re-
sponse to BRAF and MEK inhibitor therapy. This study investigated the
relationship between clinicopathological characteristics of primary and
metastatic melanomas with BRAF mutation status, in cases sent for test-
ing in the period 2012-2016.
Methods: A total of 519 samples were identified. Patient age, gender
and melanoma reporting dataset items were gathered from the histol-
ogy report. Each variable was analysed against BRAF mutation
status.
Results: 58% of patients were male and 42% were female with similar
mutation rates for both (37% and 38% respectively). 40% of the samples
were primary tumours, 57% were metastases and 3% were recurrences.
74% of mutations were v600E and there was no significant difference in
type of mutation between primary and metastatic tumours. BRAF muta-
tions were more common in metastases than primary tumours
(41% and 33% respectively). BRAF mutation was significantly
associated with superficial spreading and nodular histological sub-
types; younger age; and location of metastasis. High rates of
BRAF mutation were seen in brain metastases (78% positive).
BRAF mutation was not associated with mitotic count, Breslow
thickness, or ulceration.
Conclusion: BRAF mutation in our cohort is more common in younger
patients and in metastatic tumours, in keeping with the published litera-
ture. We found high rates of mutation in metastasis to the brain, the
reasons for which are unclear.
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Background & objectives: Granular cell tumour (GCT), is an uncom-
mon soft tissue neoplasm of neural in origin. These tumours are usually
slow growing and benign. The malignant counterpart is extremely rare in
the skin with a potential to metastasize.
Methods:Histologically, this can be diagnosed using the Fanburg-Smith
criteria. We report a series of 3 cases with a histological diagnosis of
granular cell tumour with malignant potential and evaluate the clinical
presentation, investigations and progress.
Results: Case1-7 year-old boy presents a growing lump on his right
shoulder. Histology revealed an incompletely excised GCT with atypia.
Wider excision was consistent with a malignant GCT. Case2- 67 year-old
female with firm nodule on her abdomen. Excised lesion revealed an
atypical GCT. Consensus was to manage as a potentially malignant
GCT. Case3-72 year-old man presents with a rapidly growing nodule
on his right eyebrow. Excision biopsy favoured malignant GCT.
Conclusion: Clinical diagnosis of GCTs are difficult and should be in-
cluded in the differential diagnoses of head and neck cutaneous lesions.
Clinicians should be aware that atypical and malignant variants exist.
There is some degree of pathological debate regarding classification of
these lesions, especially in borderline atypical/malignant cases. There is a
lack of consensus regarding the optimal management of this tumour but
in our experience, we recommend a wide local excision for all GCTs and
discussion at the multi-disciplinary team level.
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Background & objectives: The aim of our study was to establish a
>model imitating of UV-B (wavelength peak is 311 nm) therapy for rat’s
skin and to find match macroscopical and following histological skin
changes including melanocytes spreading and melanin distribution.
Methods:We used 6 laboratory rats with white and 12with black coating
applying UV-B light source (9 W power) during minimal erythe-
ma dose. The changes were studied by macroscopical and histo-
logical methods.
Results: In 3 of 18 of observations transitional symptoms looking alike,
actinic keratosis occurred (1 black, 2 white rats). Other passing side ef-
fects (exfoliation, erythema) occurred and were successfully removed
with exposure correction. Typical histological changes (chronic inflam-
mation, hyperkeratosis, epidermal cells dystrophy) are more noticeable in
rats with side effects, but still present in the rest of rats. Expected changes
of melanocytes and melanin distribution could not be displayed with
routine histological staining.
Conclusion:UV-B therapy model is a valid method to investigate it itself
or to investigate chronic UV-exposure effects. The typical histological
effects following UV-B exposure and their depending on macroscopical
changes were found.
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Background & objectives: The use of immunohistochemistry to assess
the number of CD3 and CD8 lymphocytes and an objective assessment of
mitotic index, using computer-assisted image analysis allows for a more
accurate assessment of the values of these parameters.
Methods: Our study included primary tissues from 88 non-consecutive
cutaneous melanoma patient who were retrospectively examined at Maria
Sklodowska-Curie National Research Institute of Oncology, Gliwice in
2005-2008 years.We used to determine themitotic index Phosphohistone
H3, Rabbit Polyclonal Antibody (PHH3) and to determine TILs
:Polyclonal Rabbit Anti-Human CD3 and Monoclonal Mouse Anti-
Human CD8.
Results: Statistically significant differences were found in the number of
CD8 lymphocytes depending on the depth of the infiltrate (p <0.01), in
the number of lymphocytes depending on the stage (p <0.05). Differences
in lymphocyte counts between T1 and T3 (p <0.05) and T1 and T4 (p
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